Chaperone Therapeutics' Unattributed Round

Chaperone Therapeutics raised a round of funding on January 12, 2017.

Chaperone Therapeutics develops therapies to address diseases of protein misfolding, which is the underlying cause of neurodegenerative and other rare diseases.…

Articles about Chaperone Therapeutics' Unattributed Round: